Mangoceuticals (MGRX) Free Cash Flow (2023 - 2026)

Mangoceuticals' Free Cash Flow history runs 4 years deep, the most recent figure standing at -$1.3 million for Q1 2026.

• In Q1 2026, Free Cash Flow rose 42.35% year-over-year to -$1.3 million; the TTM figure through Mar 2026 stood at -$4.9 million (up 20.51% YoY), while the FY2025 annual figure was -$5.9 million, down 20.28% from the prior year.
• Free Cash Flow came in at -$1.3 million for Q1 2026 at Mangoceuticals, down from -$1.1 million in the prior quarter.
• In the past five years, Free Cash Flow ranged from a high of -$991131.0 in Q1 2024 to a low of -$2.3 million in Q1 2025.
• A 4-year average of -$1.5 million and a median of -$1.3 million in 2026 frame the typical range for Free Cash Flow.
• Across the five-year window, Free Cash Flow soared 45.3% in 2024 and plunged 129.51% in 2025, its largest moves.
• Mangoceuticals' Free Cash Flow stood at -$1.7 million in 2023, then soared by 33.47% to -$1.1 million in 2024, then rose by 4.59% to -$1.1 million in 2025, then decreased by 21.67% to -$1.3 million in 2026.
• According to Business Quant data, Free Cash Flow over the past three periods registered -$1.3 million, -$1.1 million, and -$1.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison